Former FDA Leaders Denounce New Vaccine Safety Claims
A dozen former leaders of the U.S. Food and Drug Administration (FDA), appointed by both Republicans and Democrats, have issued a scathing denunciation of new claims made by the agency’s current vaccine chief, Dr. Vinay Prasad, casting doubt on vaccine safety. The former officials argue that the proposed changes to the FDA’s handling of life-saving vaccines for flu, COVID-19, and other respiratory diseases would “disadvantage the people the FDA exists to protect, including millions of Americans at high risk from serious infections.”
The former FDA commissioners and acting commissioners, who have extensive experience in the field of vaccine development and regulation, wrote in The New England Journal of Medicine that the proposed new directives are not small adjustments or coherent policy updates, but rather a major shift in the FDA’s understanding of its job. They express concern that the changes would slow innovation, make the process less transparent to the public, and reject long-standing science about how to evaluate vaccines being updated to better match virus strains.
Concerns Over Vaccine Safety and Efficacy
According to sources familiar with the internal memo, Dr. Prasad’s review found that at least 10 children have died after receiving COVID-19 vaccination, allegedly due to myocarditis, or the inflammation of the heart muscle. However, the former FDA leaders argue that this claim is based on a surveillance system that doesn’t contain medical records or other information sufficient to prove a link, and that government scientists had carefully combed through those reports in previous years, reaching different conclusions. They also note that substantial evidence shows COVID-19 vaccines reduce children’s risk of severe disease and hospitalization.
Many doctors and public health experts have expressed alarm about the memo, with Dr. Ronald Nahass, president of the Infectious Diseases Society of America, stating that “vaccines save lives, period” and that it is a sad day when the FDA creates confusion and mistrust without supplying evidence. The FDA’s planned vaccine changes come at a time when Health Secretary Robert F. Kennedy Jr. is seeking to broadly remake federal policies on vaccines, having already ousted a committee that advised the U.S. Centers for Disease Control and Prevention (CDC) on vaccine recommendations and replaced it with handpicked members.
Expert Opinion and Context
Dr. Céline Gounder, an expert in the field of infectious diseases, contributed to this report, highlighting the importance of evidence-based decision-making in vaccine policy. The CDC’s vaccine advisory committee will meet Thursday and Friday to discuss hepatitis B vaccinations in newborns and other vaccine topics, amid concerns over the FDA’s planned changes. As the debate over vaccine safety and efficacy continues, it is essential to rely on credible sources and expert opinion to inform decision-making and ensure public trust in the vaccine development and regulatory process.
For more information on this topic, please visit Here
Image Source: www.cbsnews.com
